Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT05980195

Cognitive Improvement After Carotid Stenting in Hyperbaric Oxygen Therapy Trial

Cognitive Improvement After cARotid stEnting in HyperBaric Oxygen Therapy Trial (CARE-HBOT)

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Beijing Tiantan Hospital · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of CARE-HBOT study is to evaluate whether patients with symptomatic severe carotid artery stenosis with cognitive impairment who underwent hyperbaric oxygen therapy plus standard medical treatment after stent implantation could improve their cognitive function compared with those who underwent standard postoperative medical treatment.

Detailed description

This study is a prospective, multi-center, 1:1 randomized trial. In patients with symptomatic severe carotid artery stenosis with cognitive impairment underwent stent implantation, whether hyperbaric oxygen therapy plus standard medical treatment after stenting could improve their cognitive function compared with those who underwent standard postoperative medical treatment will be studied. Primary endpoint: Cognitive level at 6 months of follow up.

Conditions

Interventions

TypeNameDescription
PROCEDUREHyperbaric oxygen therapyHyperbaric oxygen therapy for 30 times within 50 days
DRUGStandard medical treatmentStandard medical treatment consists of dual antiplatelet treatment (aspirin 100 mg per day for the entire follow-up, clopidogrel 75 per day mg, or ticagrelor 90 mg twice per day for 3 months after stenting). Other Name: Dual antiplatelet therapy for 3 months
BEHAVIORALRisk factor managementManagement of risk factors including hypertension, diabetes, lipoprotein metabolism disorder, smoking and exercise

Timeline

Start date
2024-07-16
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-08-07
Last updated
2024-07-18

Source: ClinicalTrials.gov record NCT05980195. Inclusion in this directory is not an endorsement.